Trevena Inc (TRVN)

[XenaLives]

Really confused here - I thought "lower rates of depressed breathing" was a good thing. Haven't looked at the AF stuff directly yet.

The dramatic decline in the stock is the result of notes by Adam Feuerstein. Feuerstein pointed out several concerns associated with the announcement. Most importantly, some of the doses of oliceridine demonstrated lower rates of depressed breathing verses morphine and the only statistically significant observation was found in the lowest dose. He also pointed out that the improved tolerability was not deemed to be statistically significant.

What We'll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on TRVN. In particular, we'll be watching the coming NDA to the FDA, and we're interested in seeing if what Feuerstein pointed out becomes a hurdle to the process. We'll continue to keep a close eye on the news and bring it to you as it breaks!

http://cnafinance.com/trevena-trvn-stock-massive-declines-after-positive-study-release/13824